Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
JAMA Oncol 2021 Feb 11;[EPub Ahead of Print], FY Feng, HC Huang, DE Spratt, SG Zhao, HM Sandler, JP Simko, E Davicioni, PL Nguyen, A Pollack, JA Efstathiou, AP Dicker, T Todorovic, J Margrave, YS Liu, B Dabbas, DJS Thompson, R Das, JJ Dignam, C Sweeney, G Attard, JP Bahary, HR Lukka, WA Hall, TM Pisansky, AB Shah, SL Pugh, WU Shipley, PT TranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.